AXIOS August 15, 2024
Maya Goldman

Medicare cut deals to lower the list prices of 10 widely used drugs between 38% and 79% during the first round of government price negotiations, the Biden administration said Thursday.

Why it matters: Officials said the first-ever talks will save taxpayers $6 billion. Seniors should save $1.5 billion in out-of-pocket costs when the price changes take effect in 2026.

The big picture: The announcement caps Democrats’ decades-long push to let the government negotiate directly with manufacturers — and gives the White House a potent talking point as the presidential campaign crests.

Between the lines: The negotiations involved the government exchanging offers and counteroffers with the manufacturers.

  • For four of the drugs, Medicare wound up accepting a drug company’s counteroffer....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech
Podcast: The Scope of Medicare Fraud
A Stronger Medicare Program—Now And Into The Future
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
ACOs Saved Billions in 2023: Can They Sustain This Beyond 2025?
Telehealth under threat: Why Congress must act to save Medicare coverage [PODCAST]

Share This Article